CSI Market
Sign In | Register

Iovance Biotherapeutics inc (IOVA) Annual Balance Sheets

Annual · GAAP · USD millions
Access IOVA quarterly Balance Sheets →
From Iovance Biotherapeutics inc through Dec 31 2021, shifts in Dec 31 2025's assets and liabilities provide insight into the company's capital structure and financial stability.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent163.08
Short-term Investments, Total133.90
Cash & Short-term Investments296.00
Accounts receivable82.45
Inventories51.68
Other Current Assets0.00
Prepaid Expense And Other Assets Current11.58
Total Current Assets442.69
Equipment/Property/Plant Net131.11
Intangible Assets279.32
Long-term investments0.00
Other Assets, Noncurrent60.05
Operating Lease Right Of Use Asset45.90
Total Assets913.17
Liabilities
Accounts Payable, Current AC22.16
Accrued Liabilities And Other Liabilities111.16
Notes Payable, Current NO1.00
Total Current Liabilities138.36
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent76.23
Operating Lease Liability Current4.04
Operating Lease Liability Noncurrent44.40
Total Liabilities214.59
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock3,457.65
Retained Earnings / Accumulated Deficit-2,775.53
Other Equity16.44
Common Stockholder's Equity698.58
Preferred Stockholder's Equity0.00
Total Stockholder's Equity698.58
Liabilities & Stockholder's Equity913.17
4 historic quarters locked

Sign in to unlock the full Iovance Biotherapeutics inc balance sheet history.

Sign In Create Free Account

About Iovance Biotherapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-018899

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.